A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 37,677 shares of VRTX stock, worth $17.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
37,677
Previous 36,428 3.43%
Holding current value
$17.7 Million
Previous $15.2 Million 15.97%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$392.81 - $485.53 $490,619 - $606,426
1,249 Added 3.43%
37,677 $17.7 Million
Q1 2024

May 06, 2024

BUY
$407.69 - $446.08 $1.84 Million - $2.01 Million
4,511 Added 14.13%
36,428 $15.2 Million
Q4 2023

Feb 07, 2024

BUY
$343.0 - $410.68 $210,259 - $251,746
613 Added 1.96%
31,917 $13 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $10.6 Million - $11.3 Million
31,304 New
31,304 $10.9 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Envestnet Portfolio Solutions, Inc. Portfolio

Follow Envestnet Portfolio Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.